Axa’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,990
| Closed | -$570K | – | 1134 |
|
|
2025
Q1 | $570K | Sell |
4,990
-24,850
| -83% | -$2.84M | ﹤0.01% | 914 |
|
|
2024
Q4 | $1.5M | Buy |
29,840
+20,023
| +204% | +$1.01M | ﹤0.01% | 811 |
|
|
2024
Q3 | $454K | Sell |
9,817
-3,131
| -24% | -$145K | ﹤0.01% | 974 |
|
|
2024
Q2 | $421K | Sell |
12,948
-9,674
| -43% | -$314K | ﹤0.01% | 968 |
|
|
2024
Q1 | $570K | Buy |
+22,622
| New | +$570K | ﹤0.01% | 919 |
|
|
2023
Q1 | – | Sell |
-61,700
| Closed | -$1.25M | – | 1121 |
|
|
2022
Q4 | $1.25M | Buy |
61,700
+36,000
| +140% | +$731K | ﹤0.01% | 846 |
|
|
2022
Q3 | $659K | Sell |
25,700
-38,875
| -60% | -$997K | ﹤0.01% | 923 |
|
|
2022
Q2 | $1.54M | Buy |
64,575
+34,875
| +117% | +$829K | 0.01% | 812 |
|
|
2022
Q1 | $669K | Buy |
+29,700
| New | +$669K | ﹤0.01% | 1003 |
|
|
2021
Q3 | – | Sell |
-13,300
| Closed | -$293K | – | 1242 |
|
|
2021
Q2 | $293K | Hold |
13,300
| – | – | ﹤0.01% | 1173 |
|
|
2021
Q1 | $316K | Hold |
13,300
| – | – | ﹤0.01% | 1131 |
|
|
2020
Q4 | $348K | Hold |
13,300
| – | – | ﹤0.01% | 1117 |
|
|
2020
Q3 | $231K | Hold |
13,300
| – | – | ﹤0.01% | 1138 |
|
|
2020
Q2 | $224K | Hold |
13,300
| – | – | ﹤0.01% | 1164 |
|
|
2020
Q1 | $158K | Hold |
13,300
| – | – | ﹤0.01% | 1118 |
|
|
2019
Q4 | $161K | Hold |
13,300
| – | – | ﹤0.01% | 1141 |
|
|
2019
Q3 | $188K | Hold |
13,300
| – | – | ﹤0.01% | 1252 |
|
|
2019
Q2 | $148K | Hold |
13,300
| – | – | ﹤0.01% | 1244 |
|
|
2019
Q1 | $156K | Hold |
13,300
| – | – | ﹤0.01% | 1276 |
|
|
2018
Q4 | $178K | Hold |
13,300
| – | – | ﹤0.01% | 1246 |
|
|
2018
Q3 | $186K | Sell |
13,300
-3,500
| -21% | -$48.9K | ﹤0.01% | 1299 |
|
|
2018
Q2 | $264K | Sell |
16,800
-3,800
| -18% | -$59.7K | ﹤0.01% | 1259 |
|
|
2018
Q1 | $339K | Buy |
+20,600
| New | +$339K | ﹤0.01% | 1234 |
|